ID: ALA4552688

Max Phase: Preclinical

Molecular Formula: C23H22N2O2

Molecular Weight: 358.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(C)c2[nH]c(=O)c3ccccc3c2c1-c1ccc([C@@H](C)N)cc1

Standard InChI:  InChI=1S/C23H22N2O2/c1-13-12-19(27-3)20(16-10-8-15(9-11-16)14(2)24)21-17-6-4-5-7-18(17)23(26)25-22(13)21/h4-12,14H,24H2,1-3H3,(H,25,26)/t14-/m1/s1

Standard InChI Key:  BWZKFGPGMOSNJU-CQSZACIVSA-N

Associated Targets(Human)

PDZ-binding kinase 995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.44Molecular Weight (Monoisotopic): 358.1681AlogP: 4.69#Rotatable Bonds: 3
Polar Surface Area: 68.11Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 4.28CX LogD: 2.25
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -0.15

References

1. Hu QF, Gao TT, Shi YJ, Lei Q, Liu ZH, Feng Q, Chen ZJ, Yu LT..  (2019)  Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.,  162  [PMID:30453248] [10.1016/j.ejmech.2018.11.007]

Source